0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.74%
Revenue growth similar to 0376.HK's 0.71%. Walter Schloss would see if both companies share industry tailwinds.
44.00%
Gross profit growth above 1.5x 0376.HK's 0.71%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
175.08%
EBIT growth below 50% of 0376.HK's 814.71%. Michael Burry would suspect deeper competitive or cost structure issues.
175.08%
Operating income growth above 1.5x 0376.HK's 88.58%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
228.07%
Net income growth above 1.5x 0376.HK's 70.90%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
228.28%
EPS growth above 1.5x 0376.HK's 71.12%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
228.28%
Diluted EPS growth above 1.5x 0376.HK's 71.12%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.00%
Share reduction more than 1.5x 0376.HK's 0.39%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.00%
Reduced diluted shares while 0376.HK is at 0.39%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-99.98%
Dividend reduction while 0376.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-63.53%
Negative OCF growth while 0376.HK is at 13.61%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.45%
Negative FCF growth while 0376.HK is at 9.74%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-51.09%
Negative 10Y revenue/share CAGR while 0376.HK stands at 1929.13%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
8.87%
5Y revenue/share CAGR under 50% of 0376.HK's 3636.41%. Michael Burry would suspect a significant competitive gap or product weakness.
-51.44%
Negative 3Y CAGR while 0376.HK stands at 28.95%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2256.08%
Negative 10Y OCF/share CAGR while 0376.HK stands at 593.94%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2477.32%
Negative 5Y OCF/share CAGR while 0376.HK is at 914.38%. Joel Greenblatt would question the firm’s operational model or cost structure.
5.55%
3Y OCF/share CAGR under 50% of 0376.HK's 95.49%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-9.39%
Negative 10Y net income/share CAGR while 0376.HK is at 87.97%. Joel Greenblatt sees a major red flag in long-term profit erosion.
37.21%
Below 50% of 0376.HK's 75.89%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
153.00%
Positive short-term CAGR while 0376.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
65.53%
Below 50% of 0376.HK's 519.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
71.18%
5Y equity/share CAGR above 1.5x 0376.HK's 43.34%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-9.27%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-99.92%
Cut dividends over 10 years while 0376.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-99.99%
Negative near-term dividend growth while 0376.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.71%
AR growth of 9.71% while 0376.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-1.97%
Inventory is declining while 0376.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-6.97%
Negative asset growth while 0376.HK invests at 2.68%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.25%
Positive BV/share change while 0376.HK is negative. John Neff sees a clear edge over a competitor losing equity.
-16.11%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-32.73%
Our R&D shrinks while 0376.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-4.50%
We cut SG&A while 0376.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.